- Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX(TM)) in Korean Adults
-
Choi WS, Choi JH, Choi JY, Eom JS, Kim SI, Pai H, Peck KR, Sohn JW, Cheong HJ
- KMID: 2359986
- J Korean Med Sci.
- 2016 Jan;31(1):13-17.
- doi: 10.3346/jkms.2016.31.1.13
A live attenuated zoster vaccine (ZOSTAVAX(TM), Merck & Co., Inc.) was approved by the Korea Ministry of Food and Drug Safety in 2009. However, the immunogenicity and safety of the... -
- CITED
-
- Close
- SHARE
-
- Close
